Single-Session laser combo could simplify prostate cancer care

NCT ID NCT07526675

Not yet recruiting Disease control Sponsor: Benha University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new approach called Bioblation, which combines a prostate biopsy with laser ablation in a single session under local anesthesia. It is for men with severe urinary symptoms and suspected low- to intermediate-risk prostate cancer. The goal is to see if this one-stop procedure can effectively diagnose and treat the cancer while quickly improving symptoms and reducing the need for multiple procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: laser ablation (Elesta system)
What this could lead to: If successful, this could offer a one-stop procedure to diagnose and treat low-risk prostate cancer while relieving urinary symptoms, reducing the need for multiple separate visits.
What could go wrong: This is a small, early-stage study with only 30 participants and no control group. It may not prove better than standard care, and there are risks like infection, bleeding, or incomplete treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Lower Urinary Tract Symptoms prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN PROSTATIC HYPERPLASIA LOWER URINARY TRACT SYMPTOMS (LUTS) PROSTATE CANCER

Contacts and locations

Locations

Urology Department, Benha University Hospitals

Banhā, Qalyubia Governorate, 13518, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.